跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 34,818 条关于
“SK Life Science”
全部
34,818
临床试验
19,684
药物
1,072
机构
761
资讯
13,301
5个月前
SK Life Science to Present Comprehensive Cenobamate Data and Patient-Provider Communication Study at AAN 2026
6个月前
SK Biopharmaceuticals Acquires Full Control of U.S. R&D Unit with $36 Million Investment to Advance Cancer Pipeline
去年
Clinical Trials Offer Hope for Children and Teens with Uncontrolled Seizures
去年
Clinical Trials Offer Hope for Children and Teens with Uncontrolled Seizures
前天
Japan Approves Ono's XCOPRI (Cenobamate) for Partial-Onset Seizures After Phase 3 Win
23天前
SK Biopharm licenses Biohaven's Kv7 activator Opakalim in $795M deal, targeting 2029 US launch
11个月前
Ono Pharmaceutical Submits Cenobamate Application in Japan Following Successful Phase 3 Trial
10个月前
Edgewise Therapeutics Strengthens Board with Commercial Veteran Ahead of Becker Muscular Dystrophy Launch
去年
Epilepsy Drug Pipeline Shows Robust Growth with 90+ Therapies in Development Across 75+ Companies
5个月前
EMA Issues Urgent Safety Alert for Cenobamate Following Severe Liver Injury Reports
第 1 页,共 1331 页
上一页
下一页